罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08058 罗欣药业

退市 06-05 15:59:45

16.960

-0.020

-0.12%

最高16.980	最低16.940	成交量72.00万
今开16.940	昨收16.980	日振幅0.24%
总市值103.39亿	流通市值27.91亿	总股本6.10亿
成交额1,221万	换手率0.44%	流通股本1.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"罗欣药业","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"floatShares":164560000,"shares":609600000,"eps":0.6634878930305427,"marketStatus":"退市","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":7,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08058","defaultTab":"news","newsList":[{"id":"2530055138","title":"罗欣药业：截止至 2025年4月18日，公司股东总户数为32,747","url":"https://stock-news.laohu8.com/highlight/detail?id=2530055138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530055138?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:51","pubTimestamp":1745585473,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年4月20日A股股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至 2025年4月18日，公司股东总户数为32,747 。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0239","08058","BK0001","BK0132"],"gpt_icon":0},{"id":"2529987358","title":"罗欣药业：公司2025年一季度实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2529987358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529987358?lang=zh_cn&edition=full","pubTime":"2025-04-24 20:52","pubTimestamp":1745499135,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业04月23日在投资者关系平台上答复投资者关心的问题。公司管理层通过商业模式升级、销售渠道整合、集团降本增效以及精细化运营等方式，多措并举争取扭亏。公司2025年一季度实现扭亏为盈，详情请见公司于2025年4月22日在巨潮资讯网披露的《罗欣药业：2025年一季度报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400038201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0201","BK0239","BK0001","BK0132","002793"],"gpt_icon":0},{"id":"2529462617","title":"4月24日罗欣药业（002793）涨停分析：蒙脱石散板块、业绩扭亏驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462617?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:30","pubTimestamp":1745479857,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业4月24日涨停收盘，收盘价4.72元。该股于10点17分涨停，未打开涨停，截止收盘封单资金为4890.66万元，占其流通市值0.95%。今日罗欣药业涨停的可能因素有：第一，蒙脱石散板块整体走强，市场对消化领域药品关注度提升；第二，公司2025年第一季度业绩预告显示净利润同比扭亏为盈，主要受益于创新药替戈拉生片市场份额显著提升；第三，公司在消化领域的持续技术布局及产品线拓展，增强了投资者对长期发展潜力的预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400020723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0239","002793","08058","BK0132"],"gpt_icon":0},{"id":"2529615045","title":"异动快报：罗欣药业（002793）4月24日10点17分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2529615045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529615045?lang=zh_cn&edition=full","pubTime":"2025-04-24 10:20","pubTimestamp":1745461237,"startTime":"0","endTime":"0","summary":"证券之星4月24日盘中消息，10点17分罗欣药业触及涨停板。目前价格4.72，上涨10.02%。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为化学原料药，幽门螺杆菌概念，医药概念热股，当日化学原料药概念上涨1.72%，幽门螺杆菌概念概念上涨1.26%，医药概念上涨1.03%。4月23日的资金流向数据方面，主力资金净流出2104.9万元，占总成交额15.44%，游资资金净流入667.64万元，占总成交额4.9%，散户资金净流入1437.26万元，占总成交额10.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400012252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","BK0001","002793","08058","BK0239"],"gpt_icon":0},{"id":"2529618390","title":"【化学制药板块震荡走强，河化股份、灵康药业涨停】化学制药板块震荡走强，河化股份、灵康药业涨停，尔康制药涨超10%，罗欣药业、益方生物纷纷冲高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529618390","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529618390?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:44","pubTimestamp":1745459060,"startTime":"0","endTime":"0","summary":"化学制药板块震荡走强，河化股份、灵康药业涨停，尔康制药涨超10%，罗欣药业、益方生物纷纷冲高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24094449815496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0033","688382","BK0132","01477","BK0066","BK1191","BK0056","BK0071","BK0239","BK0201","BK0028","000953","002793","300267","BK0010","BK0001","BK0004","BK1574","08058","BK0077","603669"],"gpt_icon":0},{"id":"2529690763","title":"A股化学制药板块震荡走强，河化股份、灵康药业涨停，尔康制药涨超10%，罗欣药业、益方生物纷纷冲高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529690763","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529690763?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:43","pubTimestamp":1745458981,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","BK0001","BK0004","08058","BK0071","BK0239","BK0201","BK0056","300267","BK1191","BK1574","BK0010","000953","BK0033","BK0077","603669","688382","002793","BK0066","399300","01477","BK0132","BK0028"],"gpt_icon":0},{"id":"2529699775","title":"罗欣药业（002793）2025年一季报简析：净利润增115.41%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529699775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529699775?lang=zh_cn&edition=full","pubTime":"2025-04-23 06:18","pubTimestamp":1745360304,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期罗欣药业发布2025年一季报。截至本报告期末，公司营业总收入4.83亿元，同比下降29.91%，归母净利润565.11万元，同比上升115.41%。本报告期罗欣药业盈利能力上升，毛利率同比增幅26.04%，净利率同比增幅106.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042300005951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058"],"gpt_icon":0},{"id":"2529133662","title":"图解罗欣药业一季报：第一季度单季净利润同比增115.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529133662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529133662?lang=zh_cn&edition=full","pubTime":"2025-04-22 01:46","pubTimestamp":1745257574,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业2025年一季报显示，公司主营收入4.83亿元，同比下降29.91%；归母净利润565.11万元，同比上升115.41%；扣非净利润66.9万元，同比上升101.72%；负债率63.98%，投资收益-340.7万元，财务费用1809.91万元，毛利率46.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042200001739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"gpt_icon":0},{"id":"2529660380","title":"罗欣药业(002793.SZ)发布一季度业绩，归母净利润565万元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2529660380","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529660380?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:39","pubTimestamp":1745253545,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)披露2025年第一季度报告，报告期公司实现营收4.83亿元，同比下降29.91%;归母净利润565万元，同比扭亏为盈;扣非净利润67万元，同比扭亏为盈。基本每股收益0.01元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","002793"],"gpt_icon":0},{"id":"2527101059","title":"A股化学制药板块短线拉升，罗欣药业、立方制药涨停, 山河药辅涨超10%，美诺华、森萱医药、天宇股份、昂利康、海翔药业等跟","url":"https://stock-news.laohu8.com/highlight/detail?id=2527101059","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527101059?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:34","pubTimestamp":1744684489,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603538","BK1191","08058","002940","BK0177","BK0077","BK0192","BK0001","BK1574","BK0201","BK0132","399300","159982","002793","003020","BK0188","300452","159938","BK0250","300702","002099","BK0028","BK1161","09939","01477","BK1515","BK0239"],"gpt_icon":0},{"id":"2527761155","title":"罗欣药业(002793.SZ)2024年度归母净亏损9.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527761155","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527761155?lang=zh_cn&edition=full","pubTime":"2025-04-14 19:28","pubTimestamp":1744630107,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)发布2024年度业绩快报，报告期内，公司实现营业收入26.47亿元，比去年同期增加了11.99%;归属于上市公司股东的净利润为-9.62亿元。归属于上市公司股东扣除非经常性损益的净利润为-7.71 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002793","BK0201","BK0001","08058","BK0239","BK0132"],"gpt_icon":0},{"id":"2527515546","title":"罗欣药业(002793.SZ)发预盈，预计一季度归母净利润500万元-700万元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2527515546","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527515546?lang=zh_cn&edition=full","pubTime":"2025-04-14 19:23","pubTimestamp":1744629818,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)发布2025年第一季度业绩预告，预计一季度归属于上市公司股东的净利润500万元-700万元，同比扭亏为盈。业绩变动原因：1.随着商业团队在创新药推广和医院准入工作的稳步推进，公司创新药替戈拉生片的市场份额已显著提升，渠道覆盖也持续扩大，在报告期内销售量同比增加。2.报告期内，公司通过组织应收款项的专项清收工作，有效改善公司经营性现金流的同时减少了坏账损失。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","002793"],"gpt_icon":0},{"id":"2518796873","title":"罗欣药业最新公告：注射用LX22001新增适应症获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2518796873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518796873?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:24","pubTimestamp":1741681454,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称，公司下属子公司山东罗欣药业集团股份有限公司、罗欣药业（上海）有限公司收到国家药品监督管理局下发的注射用LX22001新增适应症“预防重症患者应激性溃疡出血”《药物临床试验批准通知书》。注射用LX22001是钾离子竞争性酸阻滞剂类药物，此次新增适应症临床试验获得批准，有助于丰富产品管线，提升公司核心竞争力。但药物研发具有周期长、投入大的特点，且受行业政策等不确定因素影响，存在推进及研发效果不达预期的风险。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100028169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0001","002793","BK0201","BK0239","08058","03347","BK1576","BK1583","BK0132"],"gpt_icon":0},{"id":"2518128767","title":"罗欣药业(002793.SZ)：注射用LX22001新增适应症获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2518128767","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518128767?lang=zh_cn&edition=full","pubTime":"2025-03-11 15:45","pubTimestamp":1741679133,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)发布公告，近日，公司下属子公司山东罗欣药业集团股份有限公司、罗欣药业(上海)有限公司收到国家药品监督管理局下发的注射用LX22001新增适应症“预防重症患者应激性溃疡出血”《药物临床试验批准通知书》。公司在消化领域一直具备较强的市场竞争力，本次注射用LX22001新增适应症临床试验获得批准，体现了公司在保持该领域的技术优势的基础上持续发力，彰显了公司科技创新能力，有助于丰富产品管线，提升公司核心竞争力，符合公司战略发展需要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","BK0132","BK0239","BK1576","03347","BK0001","002793","BK1141","BK1583","BK0201"],"gpt_icon":0},{"id":"2511698005","title":"罗欣药业：3月3日将召开2025年第二次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2511698005","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511698005?lang=zh_cn&edition=full","pubTime":"2025-02-14 21:12","pubTimestamp":1739538720,"startTime":"0","endTime":"0","summary":"证券日报网讯 2月14日晚间，罗欣药业（维权）发布公告称，公司将于2025年3月3日召开2025年第二次临时股东大会。本次股东大会将审议《关于修订的议案》《关于修订的议案》。 \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-14/doc-ineknmfc7720607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["08058","002793","BK0001","BK0201","BK0132","BK0239"],"gpt_icon":0},{"id":"2505850344","title":"罗欣药业（002793）股东山东罗欣控股有限公司质押1650万股，占总股本1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505850344","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505850344?lang=zh_cn&edition=full","pubTime":"2025-01-24 21:24","pubTimestamp":1737725067,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业1月24日公开信息显示，股东山东罗欣控股有限公司向深圳市佳银典当有限公司合计质押1650.0万股，占总股本1.52%。质押详情见下表：截止本公告日，股东山东罗欣控股有限公司已累计质押股份2.06亿股，占其持股总数的86.91%。罗欣药业主营业务：医药产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400052022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","BK0239","002793","BK0132","08058"],"gpt_icon":0},{"id":"2505854707","title":"罗欣药业(002793.SZ)发预亏，预计2024年度净亏损7.85亿元至9.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505854707","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505854707?lang=zh_cn&edition=full","pubTime":"2025-01-24 20:55","pubTimestamp":1737723345,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)发布2024年度业绩预告，预计全年归属于上市公司股东净亏损7.85亿元至9.85亿元。报告期内，公司在创新药替戈拉生片的医院准入工作方面取得了显著进展，同时新的适应症也成功获批，创新药推广是一个长期且复杂的过程，需要持续的投入和努力。此外，公司为了提升品牌和产品的认知度，增强医生和患者的信任度，加大了市场推广的投入，从而为未来逐步扩大市场份额奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1243863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0132","08058","BK0001","002793","BK0201"],"gpt_icon":0},{"id":"2505888401","title":"罗欣药业（002793）1月24日主力资金净卖出506.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505888401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505888401?lang=zh_cn&edition=full","pubTime":"2025-01-24 15:33","pubTimestamp":1737704001,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月24日收盘，罗欣药业报收于3.64元，下跌1.36%，换手率1.06%，成交量11.49万手，成交额4180.62万元。1月24日的资金流向数据方面，主力资金净流出506.72万元，占总成交额12.12%，游资资金净流出9.95万元，占总成交额0.24%，散户资金净流入516.67万元，占总成交额12.36%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400027380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0201","BK0132","BK0001","BK0239","002793"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luoxin.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0433},{"period":"3month","weight":0.0937},{"period":"6month","weight":0.0787},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.1027}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东罗欣药业股份有限公司是原山东罗欣制药厂改制重组,由临沂罗欣医药有限公司控股,联合沈阳药科大学等共11家发起人共同发起设立的股份有限公司,是严格按照现代企业制度和国家GMP要求组建的制药企业,是国家级高新技术企业。公司经营范围:中西药品、医药原料药的研制、开发、生产、销售。公司建有冻干粉针剂、粉针剂、水针剂、固体制剂、头孢菌素类原料药、口服头孢系列产品等三十多条生产线,已全部通过国家GMP认证。","exchange":"SEHK","name":"罗欣药业","nameEN":"Shandong Luoxin Pharmaceutical Group"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,08058,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}